Bill Studier, the T7 System, and COVID Vaccines

January 18, 2022

When Bill Studier and his colleagues in Brookhaven Lab's Biology Department patented the T7 expression system in 1984, they didn't know more than 35 years later it would be a critical tool in the fight against a global pandemic. Pfizer-BioNTech and Moderna used the T7 system to ramp up production of their COVID-19 vaccines. John Shanklin, chair of the Biology Department today, describes Studier, his research, and his impact.